Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-088039

Chief Executive Officer gave up 58,712 shares (to pay taxes)

  • Chief Executive Officer acquired 540,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2015-12-30 Shares withheld for taxes −58,712 $6.13 $359,905 561,461 D
Anzalone Christopher Richard Chief Executive Officer 2016-01-01 Grant or award +540,000 1,101,461 D
Derivatives
Anzalone Christopher Richard Chief Executive Officer 2016-01-01 Grant or award · Stock Options +80,000 1,166,466 D
Loading xslF345X03/doc4.xml…